CELEGHINI, CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 5.719
EU - Europa 2.395
AS - Asia 602
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 3
OC - Oceania 3
Totale 8.735
Nazione #
US - Stati Uniti d'America 5.710
PL - Polonia 716
UA - Ucraina 436
SE - Svezia 405
CN - Cina 263
IT - Italia 229
FI - Finlandia 151
HK - Hong Kong 148
TR - Turchia 145
GB - Regno Unito 99
IE - Irlanda 84
BG - Bulgaria 72
CH - Svizzera 66
DE - Germania 56
FR - Francia 33
BE - Belgio 20
RU - Federazione Russa 16
VN - Vietnam 10
CA - Canada 8
SG - Singapore 6
IN - India 5
BR - Brasile 4
CL - Cile 4
EU - Europa 4
ID - Indonesia 4
KR - Corea 4
PH - Filippine 4
GR - Grecia 3
MY - Malesia 3
NL - Olanda 3
SN - Senegal 3
AU - Australia 2
JP - Giappone 2
PK - Pakistan 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AT - Austria 1
BD - Bangladesh 1
ES - Italia 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
NP - Nepal 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
TT - Trinidad e Tobago 1
Totale 8.735
Città #
Fairfield 838
Woodbridge 737
Warsaw 714
Ann Arbor 535
Houston 510
Chandler 415
Ashburn 405
Jacksonville 397
Wilmington 351
Seattle 333
Cambridge 273
Hong Kong 148
Princeton 144
Izmir 139
Beijing 81
Sofia 72
Dublin 70
Boardman 64
Bern 62
Trieste 61
San Diego 45
Dearborn 43
Menlo Park 31
Helsinki 22
Des Moines 21
Milan 21
Nanjing 21
Falls Church 16
Verona 16
Brussels 15
Ferrara 14
Chicago 13
Hefei 13
Buffalo 11
Dong Ket 10
Jinan 10
Phoenix 10
Redwood City 10
Auburn Hills 9
Kunming 9
Norwalk 9
Nanchang 8
Guangzhou 7
Washington 6
Hebei 5
Kocaeli 5
Los Angeles 5
Sacile 5
Shanghai 5
Tappahannock 5
Columbus 4
Edinburgh 4
Hangzhou 4
Shenyang 4
Zhengzhou 4
Dakar 3
Duvall 3
Fort Worth 3
Leuven 3
London 3
New York 3
Pune 3
Seoul 3
São Paulo 3
Udine 3
Wuhan 3
Ansbach 2
Baotou 2
Berlin 2
Bremen 2
Brescia 2
Chaoyang 2
Chongqing 2
Clearwater 2
Dallas 2
Dongguan 2
Kediri 2
Kuala Lumpur 2
Mestre 2
Montegaldella 2
Munich 2
Nanning 2
Ottawa 2
Redmond 2
San Jose 2
San Mateo 2
Sint-Genesius-Rode 2
Toronto 2
Xian 2
Zurich 2
Alexandria 1
Arouca 1
Athens 1
Auckland 1
Aurora 1
Bangalore 1
Birmingham 1
Bloomfield 1
Bologna 1
Budapest 1
Totale 6.880
Nome #
Geranylgeraniol and Neurological Impairment: Involvement of Apoptosis and Mitochondrial Morphology 335
Neuronal Dysfunction Associated with Cholesterol Deregulation. 322
TNF-related apoptosis inducing ligand in ocular cancers and ocular diabetic complications 290
Repositioning Of Tak-475 In Mevalonate Kinase Disease: Translating Theory Into Practice 258
In vitro evaluation of the anti-inflammatory properties of Echinacea and Ginger in normal and pathological pregnancy 255
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets? 221
Pre-eclampsia affects procalcitonin production in placental tissue 196
Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo. 158
An update on the xenograft and mouse models suitable for investigating new therapeutic compounds for the treatment of B-cell malignancies. 153
TNF-related apoptosis inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF. 152
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells. 144
Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL). 142
Effect of recombinant TRAIL in a murine co-culture system of osteoclastogenesis 140
Complement component C1q as potential diagnostic but not predictive marker of preeclampsia 139
HIV-1 Tat protects CD4+ Jurkat T lymphoblastoid cells from apoptosis mediated by TNF-related apoptosis-inducing ligand. 138
Potential role of circulating microRNAs as early markers of preeclampsia 136
Potential pathogenetic implications of cyclooxygenase-2 overexpression in Bchronic lymphoid leukemia cells 135
Extracellular Tat activates c-fos promoter in low serum-starved CD4+ T cells. 134
Anti-leukemic activity of Dasatinib in both p53(wild-type) and p53(mutated) B malignant cells. 133
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 133
Association of serum tumor necrosis factor-related apoptosis inducing ligand with body fat distribution as assessed by dual X-Rays absorptiometry 132
Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells. 131
Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside. 131
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction. 129
Total extract of Beta vulgaris var. cicla seeds versus its purified phenolic components: antioxidant activities and antiproliferative effects against colon cancer cells. 126
PMA-induced megakaryocytic differentiation of HEL cells is accompanied by striking modifications of protein kinase C catalytic activity and isoform composition at the nuclear level. 123
Functional expression of TRAIL and TRAIL-R2 during human megakaryocytic development 123
Recent advances in the therapeutic perspectives of Nutlin-3 123
The potential role of Nutlins in the treatment of B-chronic lymphocytic leukemia (B-CLL). 122
Human full-length osteoprotegerin induces the proliferation of rodent vascular smooth muscle cells both in vitro and in vivo. 122
Upregulation of SOCS-1 by Nutlin-3 in acute myeloid leukemia cells but not in primary normal cells 119
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells. 117
Treatment with recombinant tumor necrosis factor-related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetes 116
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 115
In vivo and in vitro modulatory effect of human immunodeficiency virus type-1 (HIV-1) Tat protein on protein kinase C activity. 114
Insulin down-regulates TRAIL expression in vascular smooth muscle cells both in vivo and in vitro. 113
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines. 113
Thrombopoietin enhances the aIIbb3-dependent adhesion of megakaryocytic cells to fibrinogen or fibronectin through PI 3 kinase. 111
Tat-expressing Jurkat cells show an increased resistance to different apoptotic stimuli, including acute human immunodeficiency virus-type 1 (HIV-1) infection. 110
Activation of the nitric oxide synthase pathway represents a key component of tumor necrosis factor-related apoptosis-inducing ligand-mediated cytotoxicity on hematologic malignancies. 108
Design, Synthesis, and Biological Characterization of Novel Mitochondria Targeted Dichloroacetate-Loaded Compounds with Antileukemic Activity 108
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 108
Tumour necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells. 106
Selective modulation of specific protein kinase C (PKC) isoforms in primary human megakaryocytic vs. erythroid cells. 105
The expression levels of the pro-apoptotic XAF-1 gene modulate the cytotoxic response to Nutlin-3 in B chronic lymphocytic leukemia. 103
Tumor necrosis factor-related apoptosis-inducing ligand induces monocytic maturation of leukemic and normal myeloid precursors through a caspase-dependent pathway. 101
Perifosine plus nutlin-3 combination shows a synergistic anti-leukaemic activity. 101
Human herpesvirus 7 induces the functional up-regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) coupled to TRAIL-R1 down-modulation in CD4+ T cells. 100
Association of PI 3-K with tyrosine phosphorylated Vav is essential for its activity in neutrophil-like maturation of myeloid cells. 99
Soluble TRAIL is present at high concentrations in seminal plasma and promotes spermatozoa survival. 99
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells. 98
Modulation of the expression and activity of cyclooxygenases in normal and accelerated erythropoiesis. 97
HIV-1 Tat protein suppresses the nerve growth factor (NGF)-mediated differentiation of PC12 rat pheochromocytoma cell line. 94
MDM2 non-genotoxic inhibitors as innovative therapeutic approaches for the treatment of pediatric malignancies 94
In vitro senescence and apoptotic cell death of human megakaryocytes. 92
Impaired survival of bone marrow GPIIb/IIIa+ megakaryocytic cells as an additional pathogenetic mechanism of HIV-1-related thrombocytopenia. 92
Activation of PKC-epsilon counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members. 92
The induction of megakaryocyte differentiation is accompanied by selective Ser133 phosphorylation of the transcription factor CREB in both HEL cell line and primary CD34+ cells. 90
Recombinant TRAIL induces miorelaxating activity in rat aortas, which is abrogated by the induction of diabetes mellitus 89
PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines 89
NF-κB pathways in hematological malignancies 85
Differential effects of stromal derived factor-1a (SDF-1a) on early and late stages of human megakaryocytic development. 83
Erythropoietin-induced erythroid differentiation of K562 cells is accompanied by the nuclear translocation of phosphatidylinositol 3-kinase and intranuclear generation of phosphatidylinositol (3,4,5) trisphosphate. 81
MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib. 81
Release of a specific set of proinflammatory adipokines by differentiating 3T3-L1 cells 81
All-Trans retinoic acid potentiates megakaryocyte colony formation: in vitro and in vivo effects after administration to acute promyelocytic leukemia patients. 73
The engagement of CD4 surface antigen in the HEL haemopoietic cell line up-regulates the transforming growth factor-b1 (TGF-b1) promoter activity. 70
Subcellular localization of the regulatory HIV-1 Tat protein produced endogenously by or added exogenously to PC12 rat pheochromocytoma and human Jurkat T lymphoid cells. 66
Levels of circulating TNF‑related apoptosis‑inducing ligand in celiac disease 61
Morphological features of apoptosis in hematopoietic cells belonging to the T-lymphoid and myeloid lineages. 59
In situ polymerase chain reaction tecnique revealed by flow cytometry as a tool for gene detection. 56
Pleiotropic effects of immobilized versus soluble recombinant HIV-1 Tat protein on CD3-mediated activation, induction of apoptosis, and HIV-1 long terminal repeat transactivation in purified CD4+ T lymphocytes. 51
Totale 8.916
Categoria #
all - tutte 19.938
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.938


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019741 0 0 0 0 0 0 0 0 0 0 489 252
2019/20202.319 149 129 113 424 165 296 262 241 190 101 144 105
2020/20211.316 128 85 120 174 98 142 97 108 70 135 38 121
2021/2022792 37 51 32 67 31 80 44 23 97 91 74 165
2022/20231.166 94 125 84 170 118 231 1 108 172 6 44 13
2023/2024564 93 48 37 55 48 52 120 101 5 5 0 0
Totale 8.916